Mead Johnson and Abbott Laboratories are to face a new trial in the US over allegations their premature infant formula can ...

Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low ...

Reckitt Benckiser Group PLC hit a new 52-week high, surpassing its previous peak of £53.86, which the company achieved on ...

BofA downgraded Reckitt Benckiser (RBGLY) to Neutral from Buy citing a lack of near-term catalysts and its preference for Unilever. Effectively assess a stock's risks and opportunities with a ...

Berenberg analyst Fulvio Cazzol raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,920 GBp from 5,177 GBp and keeps a Hold rating ...

Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on high ...

Reckitt Benckiser is moving forward with the sale of its nutrition operations housing the Mead Johnson infant-formula ...

(RTTNews) - British nutrition products maker Reckitt Benckiser (RBGPF.PK ... Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new ...

Reckitt Benckiser’s profits fell short of analysts’ expectations ... high-margin powerbrands,” said Licht. Reckitt’s new strategy sees it structured into three divisions: Reckitt, Essential Home and ...

Revenue: UK£14.2b (down 3.0% from FY 2023). Net income: UK£1.43b (down 13% from FY 2023). Profit margin: 10% (down from 11% in FY 2023). EPS: UK£2.04 (down from UK£2.28 in FY 2023). Revenue ...

Reckitt Benckiser's shares rose after the company ... and simplify the organization in order to accelerate growth. The new structure consists of a core group of 11 major brands, representing ...

Reckitt Benckiser, the Indian arm of $5-billion Reckitt Benckiser Plc, has launched two new versions of its 24-year old brand Dispirin for various therapeutic uses. - Reckitt Benckiser (India ...